乳腺癌患者化疗期植入式输液港与PICC受益的对比性研究  

Comparison of the Benefits of Embedded Venous Transfusion and PICC in Patients With Breast Cancer During Chemotherapy

作　　者：黄霞 潘兴艳 覃智琴 田旭珊 杨艳飞 HUANG Xia;PAN Xingyan;QIN Zhiqin;TIAN Xushan;YANG Yanfei(Brest and Thyroid Surgery Department,Tongren People＇s Hospital,Tongren Guizhou 554300,China)

机构地区：[1]贵州省铜仁市人民医院甲乳外科,贵州铜仁554300

出　　处：《中国继续医学教育》2018年第31期153-155,共3页China Continuing Medical Education

基　　金：贵州省铜仁市科技计划面上项目(铜市科研[2017]47-22号)

摘　　要：目的对外周静脉置入中心静脉导管(PICC)与植入式静脉输液港(PORT)在乳腺癌化疗期的受益性比较。方法将我院2015年9月—2018年5月化疗的乳腺癌患者80例分为PICC组(n=40)及PORT组(n=40),比较两组置管并发症、维护时间、维护次数、患者生活质量等。结果 PORT组的并发症低于PICC组,维护次数、时间少于PICC组。PORT组生活质量优于PICC组,差异有统计学意义(P <0.05)。结论 PORT患者受益性明显高于PICC组。PORT可推荐为乳腺癌化疗期深静脉置管的理想选择。Objective To compare the beneficial effects of peripherallyinserted central catheter （PICC） and implantable venous port （PORT）in the treatment of breast cancer during chemotherapy. Methods80 breast cancer patients with chemotherapy from September2015 to May 2018 in our hospital were divided into group PICC（n=40） and group PORT （n=40）. The complications, maintenancetime, maintenance times and quality of life of the two groups werecompared. Results The complications in group PORT were lowerthan those in group PICC, and the maintenance time and maintenancetimes were less than those in group PICC, the quality of life in groupPORT was signifcantly better than that in group PICC, the diferencewas statistically signifcant （P 〈 0.05）. Conclusion the beneft of PORTpatients was signifcantly higher than that of the PICC group. PORT canbe recommended as an ideal choice for deep vein catheterization duringbreast cancer chemotherapy.

关 键 词：植入式静脉输液港 PICC 乳腺癌 化疗方式 受益对比 临床应用 

分 类 号：R473[医药卫生—护理学]